This ruling is procedurally final and has no material impact on AstraZeneca's stock or operations. No further trading action warranted based on this filing.
Price Chart
Executive Summary
The U.S. District Court for the District of Maryland denied plaintiff Monique Richards Smith's motion to alter or amend judgment in an ADA discrimination and retaliation suit against AstraZeneca Pharmaceuticals LP. The court had previously granted summary judgment to AstraZeneca, and the denial of this post-judgment motion confirms that the case remains closed with no liability for the company.
Court Ruling Details
Key Facts
- The Court granted AstraZeneca's motion for summary judgment on all ADA claims on March 17, 2026.
- Plaintiff's motion to alter or amend judgment (Rule 59(e)) was denied on August 18, 2026.
- The case involves a single former employee's individual claims — no class action, no material financial exposure, and no business impact.
- AstraZeneca's market cap is ~$248.3B, making any potential damages in this routine employment case immaterial.
Financial Impact
No damages awarded or sought stated in the opinion; a routine single-plaintiff employment discrimination case with no financial exposure relative to AstraZeneca's size.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion from CourtListener.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-fafddc1e09-AZN |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 6-K | $161.85 $168.37 | ▲ +4.03% | ▲ +1.90% | $156.97 (−3.02%) |
Sep 14, 2026 18d ago | 6-K | $163.78 $168.10 | ▼ −2.64% | ▼ −2.53% | $156.97 (+4.16%) |
Sep 8, 2026 24d ago | 6-K | $160.04 $161.85 | ▲ +1.13% | ▲ +2.25% | $156.97 (−1.92%) |
Sep 1, 2026 4w ago | 6-K | $162.22 $156.94 | ▼ −3.25% | ▼ −3.33% | $156.97 (−3.23%) |
Sep 1, 2026 4w ago | 6-K | $162.22 $156.94 | ▼ −3.25% | ▼ −3.33% | $156.97 (−3.23%) |
Sep 1, 2026 4w ago | 6-K | $162.47 $156.94 | ▼ −3.40% | ▼ −3.49% | $156.97 (−3.39%) |
Sep 1, 2026 4w ago | 6-K | $162.22 $156.94 | ▼ −3.25% | ▼ −3.33% | $156.97 (−3.23%) |
Sep 1, 2026 4w ago | 6-K | $162.22 $156.94 | ▼ −3.25% | ▼ −3.33% | $156.97 (−3.23%) |
Sep 1, 2026 4w ago | 6-K | $162.47 $156.94 | ▼ −3.40% | ▼ −3.49% | $156.97 (−3.39%) |
Aug 31, 2026 4w ago | Court Ruling | $162.13 $159.95 | ▲ +1.34% | ▲ +1.20% | $156.97 (+3.18%) |
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access